Frequent reconstitution of IDH2(R140Q) mutant clonal multilineage hematopoiesis following chemotherapy for acute myeloid leukemia.
Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
D H
DH
Wiseman
Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
E L
EL
Williams
Manchester Cancer Research Centre Biobank, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
D P
DP
Wilks
Computational Biology, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
H
H
Sun Leong
Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
T D D
TD
Somerville
Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
M W
MW
Dennis
Metabolic Laboratory, Department of Clinical Chemistry, Free University Medical Center, Amsterdam, The Netherlands.
E A
EA
Struys
Metabolic Laboratory, Department of Clinical Chemistry, Free University Medical Center, Amsterdam, The Netherlands.
A
A
Bakkali
Metabolic Laboratory, Department of Clinical Chemistry, Free University Medical Center, Amsterdam, The Netherlands.
G S
GS
Salomons
Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
T C P
TC
Somervaille
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019070:Cell Lineage; D006410:Hematopoiesis / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics*; D009154:Mutation
D000970:Antineoplastic Agents; C538784:IDH2 protein, human; D007521:Isocitrate Dehydrogenase